Skip to content

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy - IGROWtoh

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07445412
Acronym
I-GROWtoh
Enrollment
2000
Registered
2026-03-03
Start date
2024-10-22
Completion date
2040-04-01
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cancer (Primary and Metastatic), Liver Hypertrophy, Liver Resection, Liver Tumours

Brief summary

The goal of this national mutlticenter observational study is to learn and describe trends over time in the use of techniques for inducing hepatic hypertrophy in Italy. Patients will be treated according to the current clinical practice of the participating centers and will be observed from the moment of recruitment and throughout their stay. Information on vital status will be collected, as far as possible, for up to 5 years after surgery in order to record any events that occur in a timely manner. There are also plans to retrospectively collect data on patients who underwent hypertrophic techniques in the previous 10 years, in order to establish a historical cohort for each center that can be used for comparison with the prospective cohort.

Interventions

None listed

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 or older * Obtaining informed consent * Patients with liver neoplasia (benign or malignant) and with a future liver remnant volume deemed insufficient (\<20%-40%) by the local multidisciplinary team

Exclusion criteria

* pregnant or breastfeeding woman

Design outcomes

Primary

MeasureTime frame
Describe the temporal trends in the use of techniques for inducing hepatic hypertrophy in Italythrough study completion, an average of 1 year
compare the techniques used in terms of function and volumetric hypertrophythrough study completion, an average of 1 year
compare the techniques used in terms of drop-outthrough study completion, an average of 1 year
compare the techniques used in terms of 90-day mortalitythrough study completion, an average of 1 year
compare the techniques used in terms of long-term survivalthrough study completion, an average of 1 year
compare the techniques used in terms of disease-free survivalthrough study completion, an average of 1 year

Countries

Italy

Contacts

CONTACTElio Jovine, MD
elio.jovine@aosp.bo.it+39 3356468200
CONTACTMatteo Serenari, MD
matteo.serenari@aosp.bo.it+39 3289277643
PRINCIPAL_INVESTIGATORElio Jovine, MD

IRCCS Policlinico di Sant'Orsola - Malpighi (Bologna, Italy)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026